Clinical & Pharma

Eli Lilly and Company, headquartered in Indianapolis, Indiana, has emerged as a titan in the pharmaceutical world, capturing global attention with a remarkable stock surge and pioneering advancements in drug development. As of November 12, 2025, the company’s market performance reflects not just

In the ever-evolving landscape of medical science, few recognitions carry the weight and prestige of the 35th Bunshu Medical Award, recently announced by the Korean Medical Association (KMA) and Korea Boehringer Ingelheim in South Korea. Established in 1990, this esteemed award not only celebrates

In the rapidly evolving landscape of global healthcare, few companies have managed to capture investor attention quite like Chugai Pharmaceutical (TSE:4519), a leading Japanese firm with a reputation for innovation and resilience. Amid rising healthcare demands and an aging population worldwide,

In a startling development that has sent ripples through the public health community, a multistate outbreak of infant botulism has been traced to a specific brand of powdered infant formula, raising urgent concerns among parents and caregivers nationwide. The Centers for Disease Control and

In a world where medical advancements hold the promise of transforming lives, the pioneering research of Joan Brugge, co-director of Harvard University’s Ludwig Center, stands out as a beacon of hope in the fight against breast cancer. Her innovative approach focuses on targeting and eliminating

In a landmark development that could transform the affordability of critical medications for millions of Americans, the Trump administration has finalized a historic agreement with pharmaceutical powerhouses Eli Lilly and Novo Nordisk to significantly reduce the prices of GLP-1 drugs by 2026. These